Timing decision · Independent Chronology Reconstruction
What is the defensible order of events and where does the account conflict?
The buyer’s decision
Buyer: Bank compliance, fintech oversight, regulated advisers and counsel. Decision trigger: Onboarding, unusual-activity escalation, sanctions or politically exposed-person flag.
Defined unit: One bounded event sequence; disclosed evidence window; source provenance and known omissions.
Research emphasis: Disambiguate entities, trace official sanctions or ownership entries and preserve provenance.. Records prioritised include official list entry, company register, original regulator notice.
Exactly what is investigated
- Confirm exact subject, legal identity and the limited research period
- Recover the agreed original records and record publication, effective and collection dates
- Which dated original official list entry most directly proves the key assertion concerning independent chronology reconstruction?
- Could similar-name false positive alter the proposed decision, and which record would disprove it?
- Test adverse or alternative evidence and distinguish absence of evidence from a negative finding
- Construct a traceable match disposition table for this decision
- Record the specific unavailable evidence and clarify what would change the conclusion
Deliverable and quality control
- Chronology chart, disputed-event table, original-record references and unresolved sequence.
- match disposition table using traceable sources
- Dated and classified findings: supported, contradicted, unresolved or out of scope
- Human review of source-to-claim traceability and privacy considerations
- Concisely stated reliance limitations and decision-owner questions
Boundary, cost and acceptance
Commercial rule: Fixed scope and fixed fee agreed in writing, with human acceptance before work begins. A fee amount is not yet approved for publication. No automatic checkout, blanket monitoring commitment, performance guarantee or prepaid credits.
- No regulated AML sign-off, screening guarantee or legal clearance; false positive risk.
- Unlimited records, new jurisdictions, third-party licensed datasets and urgent handling unless contracted
- Final legal, accounting, medical, security, engineering, valuation or regulated sign-off
For a faster decision, commission the narrowest product that can resolve the immediate evidence question. Larger dossiers are optional and should follow a documented need.
Evidence starting points and what they do not prove
These databases and materials are starting points only. We do not claim that a named buyer, project, company or occurrence has been verified on this page.
- US Treasury OFAC sanctions search Official or industry source for use if relevant, not evidence of a named case
- Dun & Bradstreet third-party risk product Official or industry source for use if relevant, not evidence of a named case
Defined evidence, not an unlimited research engagement
Decision-specific checks
- Do external identity, ownership and adverse-record signals justify further escalation?
- Independent contrary-source check and named source version/date
- Explicit not-observed / outside-mandate decision
What to provide
- Exact subject identifier and jurisdiction
- Decision date, quoted claim or document
- Permitted supporting evidence and known contrary claims
Illustrative delivery components
Dated event and exhibit chronology and a source index stating record ID, issuer, effective date, read date and unresolved matters.
Professional reliance limit
No regulated AML sign-off, screening guarantee or legal clearance; false positive risk.
Illustrative specification only. No factual conclusion or cleared buyer has been represented. Written scope, fee and researcher acceptance are required.
Evidence before commitment · clearly bounded
A specific answer for a specific decision
Did a designation or authority action precede onboarding?
What the review checks
- Record the precise named subject, stable identifier, period and claim being tested.
- Recover or request current ofac entries with designations and aliases and distinguish the original issuer from a vendor-generated summary.
- Test the adverse possibility that fuzzy name similarity without matching identifiers.
- State what cannot be established, rather than quietly converting a failed search into an exculpatory finding.
- Obtain independent human source traceability review and identify the client professional responsible for final reliance.
What you supply
- Named company or matter, relevant legal entity identifiers, jurisdiction and decision date.
- Up to the stated cap of quoted claims and original client-held documents available lawfully.
- Known alternatives, exculpatory evidence and material contrary accounts.
- Written approval of bounded deliverable, reuse/reliance limits, any paid-source costs and a human reviewer.
A human-reviewed source and contradiction assessment. No general AI answer is accepted as independent evidence. Scope, actual source availability, exclusions, fixed fee and delivery date are agreed in writing before work begins.
This specimen describes the method and possible deliverables. It is not a completed client investigation and contains no case findings.
